rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

CollPlant Biotechnologies Ltd. -

CLGN · Nasdaq

Health CareMedical DevicesNot moving yet

CLGN stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 6.0% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
15 (-4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders15-4 on the quarter
New · exited1 · 5
Reported value$581K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
PINNACLE ASSOCIATES LTDadded · filed 3 Aug 2026731,663$255K+181,434+33.0%
VILLERE ST DENIS J & CO LLCreduced · filed 7 Aug 2026606,400$212K-900−0.1%
BROWN ADVISORY INCreduced · filed 14 Aug 2026104,731$37K-14,000−11.8%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 202661,500$21K+44,700+266.1%
Pathstone Holdings, LLCunchanged · filed 13 Aug 202657,000$20K00.0%
CITADEL ADVISORS LLCadded · filed 14 Aug 202653,700$19K+21,535+67.0%
Legacy Wealth Managment, LLCunchanged · filed 13 Aug 202623,179$8,08700.0%
WATERS PARKERSON & CO., LLCunchanged · filed 30 Jul 202613,250$4,62300.0%
XTX Topco Ltdreduced · filed 14 Aug 202613,081$4,564-1,714−11.6%
UBS Group AGadded · filed 13 Aug 20261,035$361+940+989.5%
31 Mar 2023 – 30 Jun 2026
121619Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Bar Berta Abelis Company insiderVP Legal · last 3 Sep 20260 · 0
Eran Rotem Company insiderDeputy CEO and CFO · last 3 Sep 20260 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202564.8%
Operating profit marginFY 2025 · to 31 Dec 2025-484%
Free cash flow marginFY 2025 · to 31 Dec 2025-398%
Return on capital employedFY 2025 · to 31 Dec 2025-142%
Research spendFY 2025 · to 31 Dec 2025345%
Revenue growthFY 2025 · to 31 Dec 2025360%
Share count trendFY 2025 · to 31 Dec 202511.8%
Cash and equivalentsFY 2025 · to 31 Dec 2025$5.6M
Free cash flowFY 2025 · to 31 Dec 2025−$9.4M

Analyst forecasts

No analyst forecasts yet.